Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1096 of 1,261
  1. US 7150875

    Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  2. US 7150871

    Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6

    The Regents of the University of California · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  3. US 7150984

    Attenuated human rotavirus vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  4. US 7151087

    CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

    The United States of America as represented by the Department of Health and Human Resources · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  5. US 7150869

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  6. US 7151101

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Dec 19, 2006 · Expires Dec 14, 2026

    granted
  7. US 7147806

    Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

    Aphios Corporation · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  8. US 7148196

    Anticancer compounds and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  9. US 7148197

    Orally administered small peptides synergize statin activity

    The Regents of the University of California · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  10. US 7148251

    Amino ceramide-like compounds and therapeutic methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  11. US 7148376

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  12. US 7148323

    Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  13. US 7148201

    Use of human plasma hyaluronidase in cancer treatment

    The Regents of the University of California · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  14. US 7148193

    Compounds that bind to growth hormone receptor

    ANTYRA INC. · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  15. US 7147863

    UVA (> 360-400) and UVB (300-325) specific sunscreens

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  16. US 7148036

    DNA molecules encoding cartilage-derived morphogenetic proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 12, 2006 · Expires Dec 7, 2026

    granted
  17. US 7144900

    Pharmaceutical composition

    Takeda Pharmaceutical Company Limited · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted
  18. US 7144916

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted
  19. US 7144918

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted
  20. US 7144575

    Methods for selectively stimulating proliferation of T cells

    United States of America as represented by the Secretary of the Air Force · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted
  21. US 7144982

    Polypeptides with therapeutic activity and methods of use

    Regents of the University of Minnesota · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted
  22. US 7144986

    Polypeptides comprising IL-6 ligand binding receptor domains

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted
  23. US 7144867

    Anticancer glycoside compounds

    Northwestern University · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted
  24. US 7144862

    Orally administered peptides to ameliorate atherosclerosis

    The Regents of the University of California · Granted Dec 5, 2006 · Expires Nov 30, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.